SAN DIEGO, June 28, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections, today announced that the Company was added to the Russell 2000® Index at the close of market on June 24, 2011 as part of the annual reconstitution of Russell indexes.
